🧪 Torrent Pharmaceuticals Sees Strong Growth on Chronic Therapies & Global Expansion

Torrent Pharmaceuticals continues to report steady growth driven by strong demand in chronic therapies and expanding international business. The company is benefiting from growth in cardiac, diabetes, and CNS segments, while its focus on branded generics and operational efficiency is supporting margins. Expansion in regulated and emerging markets is adding to revenue visibility. Management remains optimistic, backed by healthy domestic demand, product pipeline, and global growth opportunities. 📌 StockYard Take: Strong chronic portfolio and international expansion position Torrent Pharma for sustained long-term growth. #TorrentPharma #PharmaStocks #Healthcare #GlobalGrowth #StockYardResearch